| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| J Booij, G Tissingh, A Winogrodzka, E A van Roye. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. European journal of nuclear medicine. vol 26. issue 2. 1999-04-27. PMID:9933352. |
the results of post-mortem studies point to dysfunction of the dopaminergic neurotransmitter system in patients with parkinsonism. |
1999-04-27 |
2023-08-12 |
Not clear |
| J Booij, G Tissingh, A Winogrodzka, E A van Roye. Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. European journal of nuclear medicine. vol 26. issue 2. 1999-04-27. PMID:9933352. |
this review concentrates on findings of spet and pet studies of the dopaminergic neurotransmitter system in various parkinsonian syndromes. |
1999-04-27 |
2023-08-12 |
Not clear |
| b' E Meririnne, A Kankaanp\\xc3\\xa4\\xc3\\xa4, P Lillsunde, T Sepp\\xc3\\xa4l\\xc3\\xa. The effects of diazepam and zolpidem on cocaine- and amphetamine-induced place preference. Pharmacology, biochemistry, and behavior. vol 62. issue 1. 1999-04-13. PMID:9972859.' |
drugs such as benzodiazepines, which enhance the effects of inhibitory neurotransmitter gamma-amino butyric acid (gaba), are known to modulate the mesocorticolimbic dopaminergic system, which is considered to mediate the rewarding effects of psychostimulants. |
1999-04-13 |
2023-08-12 |
rat |
| D A Hoffman, D Johnsto. Neuromodulation of dendritic action potentials. Journal of neurophysiology. vol 81. issue 1. 1999-03-22. PMID:9914302. |
activation of the dopaminergic neurotransmitter system, which is also expected to raise intracellular adenosine 3',5'-cyclic monophosphate (camp) and pka levels, increased action-potential amplitude in only a subpopulation of neurons tested. |
1999-03-22 |
2023-08-12 |
Not clear |
| R Torstenson, P Hartvig, B Långström, S Bastami, G Antoni, J Tedrof. Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone. Neuropharmacology. vol 37. issue 8. 1999-02-26. PMID:9833628. |
a priori, it can be established that l-[11c]dopa and pet provide a method not only to study the structural integrity of the presynaptic dopaminergic system but also to study the homeostasis-regulating mechanisms of this neurotransmitter system in vivo. |
1999-02-26 |
2023-08-12 |
monkey |
| K Grasing, S Ghos. Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal. Neuropharmacology. vol 37. issue 8. 1999-02-26. PMID:9833630. |
these findings indicate mechanisms of action that are specific for catecholamine neurotransmitter systems are important for demonstrating long-term changes in dopaminergic function following opiate withdrawal. |
1999-02-26 |
2023-08-12 |
human |
| D J Eve, A P Nisbet, A E Kingsbury, E L Hewson, S E Daniel, A J Lees, C D Marsden, O J Foste. Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain research. Molecular brain research. vol 63. issue 1. 1999-01-21. PMID:9838046. |
these findings provide evidence of increased activity of stn neurotransmitter systems in pd and demonstrate for the first time in any species that basal ganglia nitric oxide systems can be selectively regulated in response to changes in dopaminergic input. |
1999-01-21 |
2023-08-12 |
human |
| J Birtwistle, D Baldwi. Role of dopamine in schizophrenia and Parkinson's disease. British journal of nursing (Mark Allen Publishing). vol 7. issue 14. 1999-01-07. PMID:9849144. |
the neurotransmitter dopamine (da) and the dopaminergic neurones play an important role in schizophrenia and parkinson's disease (pd). |
1999-01-07 |
2023-08-12 |
Not clear |
| A Serretti, F Macciardi, C Cusin, E Lattuada, R Lilli, E Smerald. Dopamine receptor D4 gene is associated with delusional symptomatology in mood disorders. Psychiatry research. vol 80. issue 2. 1998-11-30. PMID:9754691. |
disturbances of the dopaminergic neurotransmitter system have been implicated in the pathogenesis of depressive symptoms. |
1998-11-30 |
2023-08-12 |
human |
| A Serretti, F Macciardi, D Di Bella, M Catalano, E Smerald. Self-esteem in remitted patients with mood disorders is not associated with the dopamine receptor D4 and the serotonin transporter genes. Psychiatry research. vol 80. issue 2. 1998-11-30. PMID:9754692. |
disturbances of the dopaminergic and serotoninergic neurotransmitter systems have been implicated in the pathogenesis of depressive symptoms. |
1998-11-30 |
2023-08-12 |
human |
| M T Lambert, C Trutia, F Pett. Extrapyramidal adverse effects associated with sertraline. Progress in neuro-psychopharmacology & biological psychiatry. vol 22. issue 5. 1998-11-18. PMID:9723116. |
these movement disorders presumably occur through an interaction between serotonergic and dopaminergic pathways, providing an important clinical correlation of interactions between these neurotransmitter systems. |
1998-11-18 |
2023-08-12 |
Not clear |
| R Stron. Neurochemical changes in the aging human brain: implications for behavioral impairment and neurodegenerative disease. Geriatrics. vol 53 Suppl 1. 1998-10-06. PMID:9745628. |
of all the neurotransmitter systems studied, age-related changes in parameters of the serotonergic, cholinergic, and dopaminergic systems are the most reliably measured. |
1998-10-06 |
2023-08-12 |
human |
| B G Polloc. Psychotropic drugs and the aging patient. Geriatrics. vol 53 Suppl 1. 1998-10-06. PMID:9745631. |
specific receptor and neurotransmitter changes associated with senescence include reductions in central cholinergic and dopaminergic activities that lead to greater sensitivity to medications acting on these systems. |
1998-10-06 |
2023-08-12 |
human |
| J F Dan. Dopaminergic amacrine cells in the retina of the possum, Trichosurus vulpecula. Visual neuroscience. vol 15. issue 4. 1998-09-28. PMID:9682872. |
this is the first analysis of the neurotransmitter content of its retinal cells and, as the possum is a nocturnal forager, it was appropriate to begin with the dopaminergic amacrine cells that form an essential link in the modulation of the rod pathways subserving nocturnal vision. |
1998-09-28 |
2023-08-12 |
Not clear |
| D E Dietrich, M Schedlowski, L Bode, H Ludwig, H M Emric. A viro-psycho-immunological disease-model of a subtype affective disorder. Pharmacopsychiatry. vol 31. issue 3. 1998-09-17. PMID:9657234. |
these neuropathological changes might influence the serotonergic or dopaminergic neurotransmitter systems. |
1998-09-17 |
2023-08-12 |
human |
| B H King, H C Cromwell, H T Lee, S P Behrstock, T Schmanke, N T Maidmen. Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Developmental neuroscience. vol 20. issue 2-3. 1998-09-11. PMID:9691192. |
multiple neurotransmitter systems have been implicated in the pathogenesis of this behavior, particularly dopaminergic, opioidergic, and serotonergic systems. |
1998-09-11 |
2023-08-12 |
rat |
| T Imamura, M Takanashi, N Hattori, M Fujimori, H Yamashita, K Ishii, A Yamador. Bromocriptine treatment for perseveration in demented patients. Alzheimer disease and associated disorders. vol 12. issue 2. 1998-09-08. PMID:9651140. |
some forms of behavioral perseveration may reflect the disruption of specific neurotransmitter systems including mesencephalic dopaminergic projection. |
1998-09-08 |
2023-08-12 |
Not clear |
| J T Coul. Neural correlates of attention and arousal: insights from electrophysiology, functional neuroimaging and psychopharmacology. Progress in neurobiology. vol 55. issue 4. 1998-08-21. PMID:9654384. |
finally, a review of psychopharmacological studies in healthy human volunteers outlines the contributions of the noradrenergic, cholinergic and dopaminergic neurotransmitter systems to the neurochemical modulation of human attention and arousal. |
1998-08-21 |
2023-08-12 |
human |
| A Dalia, N J Uretsky, L J Wallac. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity. Brain research. vol 788. issue 1-2. 1998-07-23. PMID:9554973. |
the hypothesis to be tested was that increased dopaminergic transmission induced by amphetamine in the nucleus accumbens results in increased glutamatergic neurotransmission in this brain area and that the increase in level of this neurotransmitter contributes to behavioral effects of psychostimulant drugs. |
1998-07-23 |
2023-08-12 |
Not clear |
| K E Vanove. Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice. Psychopharmacology. vol 136. issue 2. 1998-06-18. PMID:9551768. |
current data indicate that dopaminergic and glutamatergic neurotransmitter systems interact. |
1998-06-18 |
2023-08-12 |
mouse |